Quantcast

Latest Opioid Stories

2014-07-30 23:08:03

Opioid Management Toolkit includes patient questionnaires, calculators, and contracts to help physicians assess, track and monitor opioid use. Toronto, ON (PRWEB) July 30, 2014 Opioid addiction in Canada has grown starkly over the past two decades, becoming a widespread public health problem affecting individuals, families, and whole communities. In response, many physicians are requesting assistance to safely prescribe opioids for their patients. Despite the wide availability of academic...

2014-07-22 12:30:21

NSC calls on companies to take actions to combat the nation's fastest growing drug epidemic ITASCA, Ill., July 22, 2014 /PRNewswire-USNewswire/ -- The number of people overdosing from opioid prescription painkillers is staggering, killing 45 people each day. Twenty-three percent of the workforce has misused prescription painkillers, according to the National Survey on Drug Use and Health, making opioid use a serious threat to employee safety. Even when employees are taking opioid painkillers...

2014-07-22 12:29:33

PITTSBURGH, July 22, 2014 /PRNewswire/ -- Community Care Behavioral Health Organization today released guidelines for treatment and recovery practices involving the use of methadone, an opioid used to treat opioid addiction. The guidelines* - titled, "Supporting Recovery from Opioid Addiction: Community Care Best Practice Guidelines for Recovery-Oriented Methadone Maintenance" - are intended to provide direction for physicians, clinicians, agencies, and systems in the Community Care...

2014-07-16 08:28:03

FDA also approves the use of two Butrans patches for dose adjustments in appropriate chronic pain patients STAMFORD, Conn., July 16, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) approved a new 7.5 mcg/hour dosage strength of Butrans(®) (buprenorphine) Transdermal System CIII. Five strengths of Butrans will now be available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour. The Butrans Transdermal System is also...

2014-07-10 16:23:20

HARRISBURG, Pa., July 10, 2014 /PRNewswire-USNewswire/ -- On behalf of Governor Tom Corbett, the Pennsylvania Departments of Drug and Alcohol Programs and Health, in partnership with the Pennsylvania Medical Society, today released statewide guidelines to address the use of prescription opioids to treat chronic non-cancer pain. Governor Corbett directed the Departments of Drug and Alcohol Programs (DDAP) and Health to establish the Safe and Effective Prescribing Practices and Pain...

2014-07-10 08:27:14

First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. RICHMOND, Va., July 10, 2014 /PRNewswire/ -- Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is not a...

2014-07-09 08:28:33

LONDON, July 9, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has signed an agreement with a commercial contract manufacturer to commence production of its naloxone-based opioid overdose reversal treatment. Lightlake expects that this manufacturer will be able to provide sufficient manufacturing capacity at cGMP production...

2014-07-08 23:10:04

All the features that make PainEDU the leading pain education website are still available, but now with an enhanced design. Newton, MA (PRWEB) July 08, 2014 Inflexxion, Inc., a behavioral health technology company that created and maintains PainEDU.org, an educational resource for clinicians treating patients with chronic pain, is pleased to announce the completion of an updated look for the PainEDU.org website. “PainEDU is now clearer and easier for healthcare providers to find all...

2014-07-07 08:27:32

- Pre-NDA meeting scheduled with FDA in July DUBLIN and RALEIGH, N.C., July 7, 2014 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today positive top-line results from its pivotal Phase III efficacy study of BEMA buprenorphine in opioid-experienced patients. BEMA buprenorphine is being developed for the management of pain severe enough to require...

2014-07-04 23:03:32

Physical Therapy: The Key to Reducing the Risks Connected with Painkiller Use and Abuse Astoria, NY (PRWEB) July 04, 2014 Physical therapy shown to increase patients' control of pain, eliminating much of the need for painkillers. According to the Center For Disease Control, Americans makes up 5% of the world’s population, but consume 75% of the world’s prescription drugs. The most abused of these drugs is painkillers. In 2012 doctors in the United States wrote 259 million...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related